Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-20

Clinical Trial Update: Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the pharmacokinetics and pharmacodynamics of exenatide in patients with gestational diabetes and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Maisa N. Feghali, MD | Conditions: Gestational Diabetes | Phase 4 | Status: RECRUITING